Obstructive lung diseases burden and COVID-19 in developing countries: a perspective.
Journal
Current opinion in pulmonary medicine
ISSN: 1531-6971
Titre abrégé: Curr Opin Pulm Med
Pays: United States
ID NLM: 9503765
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
pubmed:
16
10
2021
medline:
2
2
2022
entrez:
15
10
2021
Statut:
ppublish
Résumé
Asthma and chronic obstructive pulmonary disease (COPD) are widely prevalent disorders, and important contributors to morbidity and mortality, in both developing and developed countries. It is conjectured that these obstructive lung diseases may have had more deleterious effects in developing nations during the 2019 coronavirus disease (COVID-19) pandemic. We provide an evidence-based perspective on the relationship between asthma/COPD prevalence and COVID-19 burden, and the impact of comorbid asthma/COPD on selected COVID-19 outcomes and healthcare utilization, with special reference to developing countries. Developing countries with higher COPD (but not asthma) prevalence appear to have higher COVID-19 related mortality. Patients with asthma (but not COPD) in developing countries may be less likely to acquire COVID-19. Published literature suggests that the overall impact of comorbid asthma or COPD on adverse COVID-19 outcomes may be broadly similar between developed and developing nations. There is paucity of information on interaction between asthma/COPD and COVID-19 in developing countries. Limited data suggest minor differences between developed and developing nations. In view of inadequacies in healthcare preparedness and delivery in several developing countries, there is a need to generate quality evidence to assess impact of obstructive lung diseases and COVID-19 on each other.
Identifiants
pubmed: 34652297
doi: 10.1097/MCP.0000000000000836
pii: 00063198-202203000-00004
pmc: PMC8815642
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
84-92Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Worldometer. COVID-19 coronavirus pandemic. https://www.worldometers.info/coronavirus/#countries . [Accessed 10 September 2021].
Walker PGT, Whittaker C, Watson OJ, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science 2020; 369:413–422.
Chronic Respiratory Disease GBD Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020; 8:585–596.
Terry PD, Heidel RE, Dhand R. Asthma in adult patients with COVID-19. Prevalence and risk of severe disease. Am J Respir Crit Care Med 2021; 203:893–905.
Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in COVID-19 hospitalizations: an overestimated risk factor? Ann Am Thorac Soc 2020; 17:1645–1648.
Aggarwal AN, Agarwal R, Dhooria S, et al. Impact of asthma on severity and outcomes in coronavirus disease 2019 patients: a systematic review and meta-analysis. Respir Care 2021; doi:10.4187/respcare.09113.
doi: 10.4187/respcare.09113
Aggarwal AN, Agarwal R, Dhooria S, et al. Impact of chronic obstructive pulmonary disease on severity and outcomes in COVID-19 patients: a systematic review. Int J Noncommun Dis 2021; 6:10–28.
Alkhathami MG, Advani SM, Abalkhail AA, et al. Prevalence and mortality of lung comorbidities among patients with COVID-19: a systematic review and meta-analysis. Lung India 2021; 38:S31–s40.
Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine 2021; 33:100789.
Gulsen A, Konig IR, Jappe U, Dromann D. Effect of comorbid pulmonary disease on the severity of COVID-19: a systematic review and meta-analysis. Respirology 2021; 26:552–565.
Pardhan S, Wood S, Vaughan M, Trott M. The risk of COVID-19 related hospitalsation, intensive care unit admission and mortality in people with underlying asthma or COPD: a systematic review and meta-analysis. Front Med (Lausanne) 2021; 8:668808.
Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-Analysis. PLoS One 2020; 15:e0233147.
Singh AK, Gillies CL, Singh R, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis. Diabetes Obes Metab 2020; 22:1915–1924.
Novosad P, Jain R, Campion A, Asher S. COVID-19 mortality effects of underlying health conditions in India: a modelling study. BMJ Open 2020; 10:e043165.
The World Bank. World Bank Country and lending groups. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups . [Accessed 15 August 2021].
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results. http://ghdx.healthdata.org/gbd-results-tool . [Accessed 15 August 2021].
Hashim MJ, Alsuwaidi AR, Khan G. Population risk factors for COVID-19 mortality in 93 countries. J Epidemiol Glob Health 2020; 10:204–208.
Aalinezhad M, Alikhani F, Akbari P, et al. Relationship between CT severity score and capillary blood oxygen saturation in patients with COVID-19 infection. Indian J Crit Care Med 2021; 25:279–283.
Abayomi A, Osibogun A, Kanma-Okafor O, et al. Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study. Glob Health Res Policy 2021; 6:26.
Aghaaliakbari F, Abbasi MA, Ranjbar M, et al. Angiotensin converting enzyme inhibitors, a risk factor of poor outcome in diabetic patients with COVID-19 infection. Iran J Kidney Dis 2020; 14:482–487.
Alizadehsani R, Alizadeh Sani Z, Behjati M, et al. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol 2021; 93:2307–2320.
Aly MM, Meshref TS, Abdelhameid MA, et al. Can hematological ratios predict outcome of COVID-19 patients? A multicentric study. J Blood Med 2021; 12:505–515.
Asghar MS, Haider Kazmi SJ, Ahmed Khan N, et al. Clinical profiles, characteristics, and outcomes of the first 100 admitted COVID-19 patients in Pakistan: a single-center retrospective study in a tertiary care hospital of Karachi. Cureus 2020; 12:e8712.
Ashinyo ME, Duti V, Dubik SD, et al. Clinical characteristics, treatment regimen and duration of hospitalization among COVID-19 patients in Ghana: a retrospective cohort study. Pan Afr Med J 2020; 37:9.
Emami A, Javanmardi F, Akbari A, et al. Survival rate in hypertensive patients with COVID-19. Clin Exp Hypertens 2021; 43:77–80.
Haw NJL, Uy J, Sy KTL, Abrigo MRM. Epidemiological profile and transmission dynamics of COVID-19 in the Philippines. Epidemiol Infect 2020; 148:e204.
Islam MZ, Riaz BK, Islam A, et al. Risk factors associated with morbidity and mortality outcomes of COVID-19 patients on the 28th day of the disease course: a retrospective cohort study in Bangladesh. Epidemiol Infect 2020; 148:e263.
Jalili M, Payandemehr P, Saghaei A, et al. Characteristics and mortality of hospitalized patients with COVID-19 in Iran: a national retrospective cohort study. Ann Intern Med 2021; 174:125–127.
Janbabaei G, Brandt EJ, Golpira R, et al. The utility of rRT-PCR in diagnosis and assessment of case-fatality rates of COVID-19 in the Iranian population. Positive test results are a marker for illness severity. medRxiv 2020; 2020.04.29.20085233.
Javanian M, Bayani M, Shokri M, et al. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study. Rom J Intern Med 2020; 58:161–167.
Mahavar S, Tyagi P, Agrawal A, et al. Clinical and epidemiological profile of Indian COVID-19 patients from Jaipur: a descriptive study. Monaldi Arch Chest Dis 2021; 91:1377.
Oduro-Mensah E, Tetteh J, Adomako I, et al. Clinical features of COVID-19 in Ghana: symptomatology, illness severity and comorbid noncommunicable diseases. Ghana Med J 2020; 54:23–32.
Otuonye NM, Olumade TJ, Ojetunde MM, et al. Clinical and demographic characteristics of COVID-19 patients in Lagos, Nigeria: a descriptive study. J Natl Med Assoc 2021; 113:301–306.
Saha A, Ahsan MM, Quader TU, et al. Characteristics, management and outcomes of critically ill COVID-19 patients admitted to ICU in hospitals in Bangladesh: a retrospective study. J Prev Med Hyg 2021; 62:E33–E45.
Shahriarirad R, Khodamoradi Z, Erfani A, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. BMC Infect Dis 2020; 20:427.
Sohrabi MR, Amin R, Maher A, et al. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: a cross-sectional analysis of over 200,000 patients in Tehran, Iran. BMC Infect Dis 2021; 21:474.
Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond) 2020; 52:902–907.
Tambe MP, Parande MA, Tapare VS, et al. An epidemiological study of laboratory confirmed COVID-19 cases admitted in a tertiary care hospital of Pune, Maharashtra. Indian J Public Health 2020; 64:S183–S187.
Zuniga-Moya JC, Norwood DA, Romero Reyes LE, et al. Epidemiology, outcomes, and associated factors of coronavirus disease 2019 (COVID-19) reverse transcriptase polymerase chain reaction-confirmed cases in the San Pedro Sula metropolitan area, Honduras. Clin Infect Dis 2021; 72:e476–e483.